Jingzhou Netchem Pharm.& Chem.Co.,Ltd was established up in 2006, and invested jointly by the Chinese-American, Dr. Xuebao Wang and Dr. Dongwei Cai , The two founders graduated from Wuhan University and Sun Yat-sen University in Guangzhou respectively in the early 1980s, and got Ph.D in the the famous Columbia University and Stanford University. They worked as the chief senior researchers in the United States, Bristol-Myers Squibb Company (Bristol Myers Squibb ), and Merck & Co., Inc. (Merck).They have accumulated nearly 20 years of experience in the field of pharmaceutical research and development. Our company in the United States has built a modern small pilot plant with excellent research equipments and technical intelligence collection systems. It is well equipped to handle production of custom chemicals ranging from few grams to multiple kilo grams; In Jingzhou we have built a modern multi-function workshop, pilot experiment devices and a quality detection center. we have the capacity to produce high-quality chemical products. The annual production reaches a few tons. Meanwhile we also offer further services to support various phases of clinical studies. such as process research, process development, final form selection for new drugs and preparation of GLP and GMP material. We mainly produce high-tech, high additional value chemicals and pharmaceutical intermediates. The representative products are urgently needed at home and abroad for respiratory failure treatment - raw medicine Lobeline, the latest generation of raw medicine for diabetes treatment- gliquidone, the new generation of intermediate of chiral drugs --chiral amines, tert-butanesulfinylimine chiral boron compound and so on. We own related intellectual property of all the above products. Jingzhou NetChem will lead the development of high-tech and high added value and will be a first- class production base of chiral drugs.
Product Categories
Jingzhou Netchem Pharm.& Chem.Co.,Ltd was established up in 2006, and invested jointly by the Chinese-American, Dr. Xuebao Wang and Dr. Dongwei Cai , The two founders graduated from Wuhan University and Sun Yat-sen University in Guangzhou respectively in the early 1980s, and got Ph.D in the the famous Columbia University and Stanford University. They worked as the chief senior researchers in the United States, Bristol-Myers Squibb Company (Bristol Myers Squibb ), and Merck & Co., Inc. (Merck).They have accumulated nearly 20 years of experience in the field of pharmaceutical research and development. Our company in the United States has built a modern small pilot plant with excellent research equipments and technical intelligence collection systems. It is well equipped to handle production of custom chemicals ranging from few grams to multiple kilo grams; In Jingzhou we have built a modern multi-function workshop, pilot experiment devices and a quality detection center. we have the capacity to produce high-quality chemical products. The annual production reaches a few tons. Meanwhile we also offer further services to support various phases of clinical studies. such as process research, process development, final form selection for new drugs and preparation of GLP and GMP material. We mainly produce high-tech, high additional value chemicals and pharmaceutical intermediates. The representative products are urgently needed at home and abroad for respiratory failure treatment - raw medicine Lobeline, the latest generation of raw medicine for diabetes treatment- gliquidone, the new generation of intermediate of chiral drugs --chiral amines, tert-butanesulfinylimine chiral boron compound and so on. We own related intellectual property of all the above products. Jingzhou NetChem will lead the development of high-tech and high added value and will be a first- class production base of chiral drugs.